key: cord-1035345-jd3at29s authors: Sherman, Fredrick T.; Lechich, Anthony J. title: Nursing home physician with normal chest X‐ray and probable COVID‐19 based on 18F‐FDG PET/CT imaging date: 2020-06-14 journal: J Am Geriatr Soc DOI: 10.1111/jgs.16680 sha: 19123683ff7cba4088b428108158a4982e8b9e08 doc_id: 1035345 cord_uid: jd3at29s nan We report the clinical, laboratory and imaging studies of a 75-year-old physician with a past history of lymphoma who cared for coronavirus disease 2019 (COVID-19) patients in a nursing home and subsequently developed systemic and laboratory findings consistent with probable COVID-19 with minimal respiratory symptoms. Two reverse transcriptasepolymerase chain reaction (RT-PCR) tests for the detection of SARS-CoV-2 nucleic acid and his chest X-ray were negative. During hospitalization, a clinical diagnosis of COVID-19 was finally confirmed based on findings suspicious for COVID-19 on 18F-FDG PET/CT imaging. The rationale for utilizing 18F-FDG PET/CT in suspected COVID-19 patients with a normal chest X-ray and selected comorbid neoplastic conditions with minimal or no respiratory symptoms and signs and the role of 18F-FDG PET/CT in elucidating the pathophysiology of COVID-19 are discussed. History: During five days prior to hospital admission, he self-quarantined with fever, headache, myalgias, anorexia, low back pain and ageusia with minimal cough and shortness of breath. A nasopharyngeal swab tested by RT-PCR was negative for SARS-CoV-2, other coronaviruses and respiratory viruses including influenza A and B. His oxygen saturation was greater than 95% on room air. Because of progressive anorexia, dehydration and weakness, he was admitted to a New York City hospital with a temperature of 39 degrees C, blood pressure 143/91, heart rate 109, respiratory rate 18 and O2 saturation of 95% on room air. See Table 1 for laboratory findings. A second nasopharyngeal swab was negative for SARS-CoV-2, other coronaviruses and a respiratory pathogen PCR panel. Because of persistent fevers and his past history of lymphoma, an 18F-FDG PET/CT scan from skull base to thigh was performed. It revealed bilateral FDG-avid peripheral ground glass This article is protected by copyright. All rights reserved. Accepted Article opacities (GGOs), multi-lobe consolidations and FDG-avid thoracic nodes suspicious for COVID-19 related infectious process (See Figure 1) . He was treated with intravenous hydration, low molecular-weight heparin, antipyretics and bed rest and discharged afebrile to home after a five-day hospitalization to self-isolate and eventually return to work. Four hospitalized adult patients with respiratory symptoms highly suspected of having COVID-19 in Wuhan, China had chest CT scan findings of GGOs and/or lung consolidations in more than two pulmonary lobes (1). Admission chest X-rays were not performed, as was taken after symptom onset. Specifically, the false negative rate of RT-PCR tests was 38% on the day of symptom onset, 20% three to four days after symptom onset and 66% two weeks after symptom onset (4). Other factors that could contribute to the two negative RT-PCR tests include sampling, storage and processing errors and different viral loads depending on stage of the disease. Most importantly, the sensitivity of chest CT for diagnosing COVID-19 has been shown to be 98% compared with 71% for RT-PCR (5). 2) The 18F-FDG-PET/CT findings in this patient are consistent with past studies showing multiple, bilateral FDG-positive GGOs, multi-lobar consolidations and evidence of lymph node involvement (6) . 3) GGOs are often unperceivable on chest radiography, particularly in patients with few symptoms or low severity. While we are not suggesting that routine 18F-FDG-PET/CT scans be done on patients suspected of COVID-19, we believe the standard This article is protected by copyright. All rights reserved. Accepted Article of care should be that patients with a clinical syndrome including respiratory symptoms and/or signs consistent with COVID-19, a negative chest X-ray and neoplastic co-morbidities have a chest CT scan (7) . Bilateral GGOs or consolidation on chest CT scan in the proper clinical situation should prompt the radiologist to suggest COVID-19 as a possible diagnosis (8) . 4) Findings consistent with COVID-19 will be found in patients having 18F-FDG-PET/CT for either staging or recurrence of malignancies. Consequently, nuclear medicine departments and staff need to assume that all patients undergoing 18F-FDG-PET/CT need to be screened before scanning, personnel properly gowned and masked, the facility properly cleaned and disinfected afterwards, and lung nodule evaluation be modified (9). 5) FDG-PET/CT is highly sensitive for detecting inflammatory disease and is a potential modality to study the inflammatory components of SARS-CoV-2 infections, monitoring disease progression and treatment effects and potentially improving patient management. In addition, FDG-PET/CT may elucidate cytokine storm focusing not only on pulmonary inflammation but also other organs that have been reported to be involved i.e. myocardium, pericardium and intestine (10) . The authors thank Debra Berg MD for her critical review and Eric Wilck MD, Jack London PhD and Larry Adel for their assistance with the CT and PET/CT images. Sensitivity of chest CT for COVID-19: Comparison to RT-PCR Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study COVID-19 pneumonia: what has CT taught us Chest CT findings in 2019 novel coronavirus (2019-nCovV) infections from China: key points for the radiologist COVID-19-nuclear medicine departments, be prepared The potential added value of FDG PET/CT for COVID-19 pneumonia Axial CT image through the thorax showing left upper lobe peripheral grand glass opacity (GGO) (thick arrow) and left lower lobe peripheral GGO Fused axial PET/CT image at the level of the carina showing left upper lobe FDGavid peripheral GGO (thick arrow) and left lower lobe FDG-avid peripheral GGO